2025-09-30
Recently, Quarkmed was awarded the "Best Partner" award by Jingxin Pharmaceutical for its outstanding professional performance and efficient project execution in the Phase III clinical trial collaboration project for hyperlipidemia in China.
This time, Quarkmed's winning of the "Best Partner" title from Jingxin Pharmaceutical is of great significance. For the first time, Jingxin Pharmaceutical has awarded such an honor to a CRO company, which is a high recognition of Quarkmed's professional and efficient performance in this collaboration. This honor not only acknowledges Quarkmed's past achievements but will also serve as motivation for us to continuously forge ahead.
As a professional clinical CRO, Quarkmed has been deeply engaged in pharmaceutical research and development since its establishment, committed to providing comprehensive and high-quality clinical research services for clients. We have established a comprehensive service system, with every strictly following international standards and regulations to ensure the scientificity, accuracy, and reliability of trial results.
Meanwhile, Quarkmed emphasizes communication and collaboration with all parties, actively establishing close cooperative relationships with sponsors, researchers, and clinical trial institutions. Through efficient communication mechanisms, we timely resolve issues encountered during project implementation, ensuring project progress and quality.
In the future, we will continue to uphold the principles of professionalism, efficiency, innovation and cooperation, continuously improve our service quality and professional capabilities, and work hand in hand with more excellent pharmaceutical companies to jointly promote the vigorous development of pharmaceutical R&D.
Address：Ping An Fortune Center, Lize Financial Business District of Beijing
